• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一名因极晚期裸金属支架血栓形成导致ST段抬高型心肌梗死和心源性休克的神经外科术后患者进行经皮冠状动脉介入治疗(PCI)期间,成功使用糖蛋白IIb/IIIa抑制剂、肝素和主动脉内球囊反搏(IABP)。

Successful use of glycoprotein IIb/IIIa inhibitor, heparin, and IABP during PCI in a post-neurosurgical patient with STEMI and cardiogenic shock due to very late bare-metal stent thrombosis.

作者信息

Akkus Nuri I, Rajpal Saurabh, Agnani Sujata

机构信息

Division of Cardiology, Louisiana State University Health Sciences Center, Shreveport, 1501 Kings Hwy, Shreveport, LA 71103, USA.

出版信息

J Invasive Cardiol. 2012 Feb;24(2):76-8.

PMID:22294539
Abstract

Stent thrombosis is not unusual in a post-operative setting. Use of heparin, aspirin, clopidogrel, and glycoprotein (GP) IIb/IIIa inhibitors in this setting needs to be balanced because of the increased risk of perioperative bleeding. This is of special concern in neurosurgery, where postoperative mass effect from bleeding in a closed space is a serious risk. We describe a unique case of inferior and anterior ST-elevation myocardial infarction in cardiogenic shock during spinal surgery with acute, very late bare-metal stent (BMS) thrombosis in the left anterior descending coronary artery and simultaneous acute thrombotic occlusion of the right coronary artery, treated by primary percutaneous intervention, intra-aortic balloon pump (IABP) support and use of GP IIb/IIIa inhibitor in addition to clopidogrel, aspirin, and heparin with good surgical and cardiac outcome. This case report describes first time use of GP IIb/IIIa inhibitor and IABP with heparin, in a patient just after spinal surgery.

摘要

支架血栓形成在术后并不罕见。由于围手术期出血风险增加,在此情况下使用肝素、阿司匹林、氯吡格雷和糖蛋白(GP)IIb/IIIa抑制剂需要权衡。这在神经外科手术中尤为令人担忧,因为在封闭空间内出血导致的术后占位效应是一个严重风险。我们描述了一例独特病例,在脊柱手术期间发生心源性休克,伴有下壁和前壁ST段抬高型心肌梗死,左前降支冠状动脉发生急性、极晚期裸金属支架(BMS)血栓形成,同时右冠状动脉发生急性血栓闭塞,通过直接经皮介入治疗、主动脉内球囊泵(IABP)支持以及除氯吡格雷、阿司匹林和肝素外使用GP IIb/IIIa抑制剂,获得了良好的手术和心脏结局。本病例报告首次描述了在脊柱手术后患者中联合使用GP IIb/IIIa抑制剂、IABP和肝素的情况。

相似文献

1
Successful use of glycoprotein IIb/IIIa inhibitor, heparin, and IABP during PCI in a post-neurosurgical patient with STEMI and cardiogenic shock due to very late bare-metal stent thrombosis.在一名因极晚期裸金属支架血栓形成导致ST段抬高型心肌梗死和心源性休克的神经外科术后患者进行经皮冠状动脉介入治疗(PCI)期间,成功使用糖蛋白IIb/IIIa抑制剂、肝素和主动脉内球囊反搏(IABP)。
J Invasive Cardiol. 2012 Feb;24(2):76-8.
2
What anti-thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: how should the HORIZONS trial change current practice?对于急性ST段抬高型心肌梗死的直接经皮冠状动脉介入治疗(primary PCI),哪种抗血栓治疗最佳:“地平线”(HORIZONS)试验应如何改变当前的治疗实践?
Catheter Cardiovasc Interv. 2008 May 1;71(6):816-21. doi: 10.1002/ccd.21518.
3
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.普拉格雷联合或不联合糖蛋白IIb/IIIa抑制剂在接受经皮介入治疗的急性冠脉综合征患者中的疗效与安全性:TRITON-TIMI 38(通过优化普拉格雷血小板抑制评估治疗转归改善情况-心肌梗死溶栓试验38)分析
J Am Coll Cardiol. 2009 Aug 18;54(8):678-85. doi: 10.1016/j.jacc.2009.05.025.
4
Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).糖蛋白IIb/IIIa抑制剂与氯吡格雷单独及联合应用于非ST段抬高型心肌梗死的有效性和安全性(来自心肌梗死国家注册研究-4)
Am J Cardiol. 2006 Nov 1;98(9):1125-31. doi: 10.1016/j.amjcard.2006.05.043. Epub 2006 Aug 31.
5
Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade. Results of the AGGRASTENT Trial.在血小板糖蛋白IIb/IIIa受体阻滞剂作用下经桡动脉支架植入进行直接经皮冠状动脉介入治疗后早期出院是可行的。AGGRASTENT试验结果
J Invasive Cardiol. 2005 Oct;17(10):512-7.
6
Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative).急性ST段抬高型心肌梗死患者在接受直接经皮冠状动脉介入治疗前上游抗血小板治疗的模式(来自CRUSADE国家质量改进计划)
Am J Cardiol. 2008 Nov 15;102(10):1335-40. doi: 10.1016/j.amjcard.2008.06.063. Epub 2008 Sep 6.
7
Safety of intra-aortic balloon pump using glycoprotein IIb/IIIa antagonists.使用糖蛋白IIb/IIIa拮抗剂时主动脉内球囊泵的安全性。
Clin Cardiol. 2009 Feb;32(2):99-103. doi: 10.1002/clc.20297.
8
Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.氯吡格雷预处理与急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后的住院病死率降低相关。
Eur Heart J. 2011 Dec;32(23):2954-61. doi: 10.1093/eurheartj/ehr360. Epub 2011 Sep 14.
9
Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.稳定型和不稳定型冠状动脉疾病经皮冠状动脉介入治疗期间的药物治疗:意大利血管成形术药物评估(IDEA)研究
Ital Heart J. 2005 Feb;6(2):106-18.
10
Antiplatelet intervention in acute coronary syndrome.急性冠脉综合征的抗血小板治疗。
Am J Ther. 2009 Sep-Oct;16(5):e29-40. doi: 10.1097/MJT.0b013e31804c7238.